Target intelligence / Profile preview

Enhancer box DNA motif (E-box) (E-box)

Target
E-box
Molecular classification
Other, DNA element
01

Overview

The Enhancer box (E-box) is a conserved DNA sequence motif, typically defined by the hexanucleotide consensus CANNTG, which acts as a pivotal regulatory element in the eukaryotic genome [1]. In neuronal gene regulatory regions, E-boxes are essential for the recruitment of basic helix-loop-helix (bHLH) transcription factors such as ASCL1, NEUROD1, and the CLOCK-BMAL1 complex [2]. These interactions are fundamental to the control of neurogenesis, the specification of neuronal identity, and the regulation of the molecular circadian clock [1, 2]. While the E-box itself is a structural DNA component and not a protein, it serves as the functional site for transcriptional complexes that are frequently dysregulated in disease [3]. For instance, the overexpression of MYC family proteins in neuroblastoma leads to aberrant E-box occupancy and uncontrolled cell proliferation [4]. Therapeutic strategies targeting this pathway often focus on small molecules or mimetic peptides that disrupt the ability of bHLH proteins to dimerize or bind to the E-box motif [4]. Consequently, the E-box is a central feature of the gene regulatory networks targeted in the treatment of various cancers and neurological disorders. The ubiquity of these motifs across the genome presents a significant challenge for achieving therapeutic specificity without inducing widespread off-target effects. References: [1] Massari, M. E., & Murre, C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Molecular and Cellular Biology. [2] Bertrand, N., et al. (2002). Determinants of cell fate specification in the developing central nervous system. Nature Reviews Neuroscience. [3] Takahashi, J. S. (2017). Transcriptional architecture of the mammalian circadian clock. Nature Reviews Genetics. [4] Prochownik, E. V., & Vogt, P. K. (2010). Therapeutic Targeting of Myc. Genes & Cancer.

Other names
E-boxCANNTG motifEnhancer boxbHLH binding site
02

Mechanism of action

Inhibition of bHLH transcription factor dimerization or DNA binding

03

Biological functions

Transcription regulationNeurogenesisCircadian rhythmOther
04

Disease associations

CancerNeurodevelopmental disorderSleep disorderOther
05

Safety considerations

Genome-wide off-target effectsDisruption of normal circadian rhythmsDevelopmental toxicity
06

Interacting drugs

10058-F4

2 more in the full profile.

07

Biomarkers

MYC amplificationCLOCK expressionBMAL1 expression

Beyond the preview

Go deeper on Enhancer box DNA motif (E-box) (E-box).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enhancer box DNA motif (E-box) (E-box).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call